ProtiFi

Executive Summary

ProtiFi is the industry leader in high-throughput proteomics sample preparation, delivering reproducible and high-recovery workflows that enable precision omics research. Founded in 2018 and headquartered in San Diego, the company integrates AI and machine learning to optimize sample processing, addressing key bottlenecks in biomarker discovery and drug development. Its platform reduces variability, improves throughput, and deepens proteome coverage, making it a critical tool for academic and pharmaceutical labs. As the proteomics market expands, ProtiFi is well-positioned to capture significant share through its reliable, scalable technology. Looking ahead, ProtiFi's growth hinges on product innovation, strategic partnerships, and capital infusion. The company aims to launch next-generation sample prep solutions, form alliances with major pharma for clinical applications, and secure Series A funding to scale operations. While competition from established players exists, ProtiFi's AI-driven approach and proven reproducibility provide a competitive moat. Execution on these catalysts will determine its trajectory in the rapidly evolving proteomics landscape.

Upcoming Catalysts (preview)

• Q3 2026Next-Generation Sample Prep Platform Launch70% success
• Q4 2026Strategic Partnership with Major Pharma50% success
• Q2 2026Series A Funding Round80% success